Agonistic nanobodies and antibodies to human VISTA
The V-domain Ig Suppressor of T-cell Activation (VISTA) is an immune checkpoint regulator that suppresses immune responses and is readily expressed on human and murine myeloid cells and T cells. This immunosuppressive pathway can be activated using VISTA agonists. Here, we report the development of...
Saved in:
Main Authors: | Yu-Heng Vivian Ma (Author), Amanda Sparkes (Author), Ema Romão (Author), Shrayasee Saha (Author), Jean Gariépy (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2021-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nanobody
Published: (2021) -
Research progress and applications of nanobody in human infectious diseases
by: Yaxian Mei, et al.
Published: (2022) -
Effective targeting of microglial P2X7 following intracerebroventricular delivery of nanobodies and nanobody-encoding AAVs
by: Carolina Pinto-Espinoza, et al.
Published: (2022) -
A Synthetic Cross-Species CD200R1 Agonist Suppresses Inflammatory Immune Responses In Vivo
by: Aaron Prodeus, et al.
Published: (2018) -
Development and assessment of the efficacy and safety of human lung-targeting liposomal methylprednisolone crosslinked with nanobody
by: Dong Weng, et al.
Published: (2021)